Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase 2 belimumab study in primary Sjogren's syndrome
2009-015978-35Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of belimumab in Sjögren's syndrome (SS), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Primary efficacy endpoint and Tolerability and safety. Started Oct 2009; status: active.
02
Drugs
belimumab
03
Conditions
Sjögren's syndrome (SS)
Beyond the preview
Go deeper on 2009-015978-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015978-35.